1. TRIP12 as a mediator of human papillomavirus/p16-related radiation enhancement effects
   L Wang et al, 2017, Oncogene CrossRef
2. Centrosome aberrations in human mammary epithelial cells driven by cooperative interactions between p16INK4a deficiency and telomere-dependent genotoxic stress
   Daniel Domínguez et al, 2015, Oncotarget CrossRef
3. A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
   Rishabh Kala et al, 2016, PLOS ONE CrossRef
4. Epigenetic alterations in endocrine-related cancer
   Sandra Rodríguez-Rodero et al, 2014, Endocrine-Related Cancer CrossRef
5. Epigenetics of Endocrine Tumors in Women and Dietary Prevention
   Donato F. Romagnolo et al, 2015, Preventive Nutrition CrossRef
6. Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
   Emily A. Saunderson et al, 2017, Nature Communications CrossRef
7. Gene promoter methylation and cancer: An umbrella review
   Emmanouil Bouras et al, 2019, Gene CrossRef
8. Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds
   Donato F. Romagnolo et al, 2016, Molecular Nutrition & Food Research CrossRef
9. Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
   Chia-Jung Li et al, 2021, Cancers CrossRef
10. DNA methylome profiling beyond promoters – taking an epigenetic snapshot of the breast tumor microenvironment
    Jana Jeschke et al, 2015, The FEBS Journal CrossRef
11. A pilot study on DNA hypermethylation status in promoter region of P16 gene in patients with sporadic breast cancer
    Kapil Bhatia et al, 2022, Medical Journal Armed Forces India CrossRef
12. EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
    Si Chen et al, 2017, Molecular Medicine Reports CrossRef